Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Grant/Award of 3,587 NBIX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 3,587 | n/a |
| May 28, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 3,888 | $609.0K |
| Feb 17, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,600 | n/a |
| Feb 3, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,096 | n/a |
| Feb 14, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,811 | n/a |
| Feb 12, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,329 | n/a |
| Feb 4, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,096 | n/a |
| Oct 7, 2024 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 1,295 | $147.2K |
| Sep 17, 2024 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 3,461 | $421.8K |
| Feb 15, 2024 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 955 | $127.1K |